Jeremy Rose, M.S.

Jeremy Rose, M.S.
Research Biologist
Head, Preclinical Development and Clinical Monitoring Facility

Jeremy Rose heads a transplantation immunology research facility that supports the clinical protocols of the Experimental Transplantation and Immunotherapy Branch through the collection of biospecimens, assistance with the preclinical development of adoptive T cell therapies, and the monitoring of engraftment, immune reconstitution, graft-versus-leukemia (GVL), and graft-versus-host disease (GVHD) following allogeneic transplantation.

Areas of Expertise

1) immune reconstitution, 2) chronic graft-versus-host disease (cGVHD)

Contact Info

Jeremy Rose, M.S.
Center for Cancer Research
National Cancer Institute
Building 10, Room 12C216
Bethesda, MD 20892-1203
Ph: 240-858-3244

The Preclinical Development and Clinical Monitoring Facility provides translational support for adoptive T cell immunotherapies, including the development of standard operating procedures (SOPs) for the clinical manufacturing of innovative T cell products. The Facility provides centralized processing and secure storage for blood, marrow and tissue biospecimens collected under Branch clinical protocols, as well as the molecular and cellular analyses in support of research endpoints.

NIH Scientific Focus Areas:
Clinical Research, Immunology

Selected Recent Publications

  1. Brudno JN, Maric I, Hartman SD, Rose JJ, Wang M, Lam N, Stetler-Stevenson M, Salem D, Yuan C, Pavletic S, Kanakry JA, Ali SA, Mikkilineni L, Feldman SA, Stroncek DF, Hansen BG, Lawrence J, Patel R, Hakim F, Gress RE, and Kochenderfer JN.
    J Clin Oncol. 36: 2267-2280, 2018. [ Journal Article ]
  2. Campian JL, Piotrowski AF, Ye X, Hakim FT, Rose J, Yan XY, Lu Y, Gress R, and Grossman SA.
    J Neurooncol. 135: 343-351, 2017. [ Journal Article ]
  3. Mazor R, Addissie S, Jang Y, Tai CH, Rose J, Hakim F, and Pastan I.
    AAPS J. 19: 117-129, 2017. [ Journal Article ]
  4. Poe JC, Jia W, Su H, Anand S, Rose, JJ, Tata PV, Suthers AN, Jones CD, Kuan PF, Vincent BG, Serody JS, Horwitz ME, Ho VT, Pavletic SZ, Hakim FT, Owzar K, Zhang D, Blazar BR, Siebel CW, Chao NJ, Maillard I, and Sarantopoulos S.
    Blood. 130: 2131-2145, 2017. [ Journal Article ]
  5. Hakim FT, Memon S, Jin P, Imanguli MM, Wang H, Rehman N, Yan XY, Rose J, Mays JW, Dhamala S, Kapoor V, Telford W, Dickinson J, Davis S, Halverson D, Naik HB, Baird K, Fowler D, Stroncek D, Cowen EW, Pavletic SZ, and Gress RE.
    J Immunol. 197: 3490-3503, 2016. [ Journal Article ]

Jeremy Rose received his M.S. from Emory University before briefly joining the National Institute of Allergy and Infectious Diseases (NIAID) at NIH.  There his research experience with HIV-1 and its accessory proteins began, spanning nearly a decade, prior to his arrival at the NCI.  As part of the Preclinical Development and Clinical Monitoring Facility, he has supported the clinical protocols of the Experimental Transplantation and Immunology Branch and contributed to studies of allogeneic transplantation and adoptive T cell therapy.


Name Position
Zhouhong Cao Biologist (Contr.)
Vicki S. Fellowes Biologist
Xiao-Yi Yan Biologist